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ABSTRACT 
 
The objective of this study was to investigate the effect of antibiotic treatment on pregnancy rate in 
repeat breeder dairy crossbred cows. Based upon culture and sensitivity test, cows were assigned into two 
groups. Genta (n = 10) cows were treated with gentamycin (100 mg/ml) and ENRO (n = 12) cows were 
treated with enrofloxacin (100 mg/ml) intramuscularly 4 ml/100 kg body weight and intra-uterine 2-4 ml 
diluted with 16 ml of physiological salt solution with 24 hours interval for five days in both groups (five 
infusions per animal on every other day basis). Control (n = 14) cows were untreated control (non-repeat 
breeder). After treatment, cows were inseminated approximately 12 h after the standing heat. Pregnancy 
diagnosis was performed by ultrasonography between days 25 and 30 post insemination. The overall 
pregnancy rates after three services among three groups were significantly different (P<0.05). The overall 
pregnancy rates after three services of Genta cows (80%) did not differ significantly (P>0.05) from Control 
cows (93%). However, overall pregnancy rates of Enro cows (33%) were lower (P<0.05) than Genta and 
Control cows.  In conclusion, the pregnancy rates could be improved by treatment with gentamycin 
compared to enrofloxacin in repeat breeder dairy crossbred cows with sub-clinical uterine infection.  
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INTRODUCTION 
 
The repeat breeding cow is one that has clinically 
normal reproductive tract with normal or nearly normal 
oestrous cycles and oestrus periods and has been bred 
two or more times to a fertile bull but failed to conceive 
(Roberts, 1971).  Incidence of repeat breeding in cows 
in various countries ranged from 10 to 18% (Kimura et 
al., 1987). Potential causes of repeat breeding include 
sub-clinical infection of reproductive tract (Rao, 1982), 
age of the animal (Bartlett et al., 1986), errors in 
detection of oestrus (DeKriuf, 1978), endocrine 
dysfunction (Gustafsson et al., 1986), nutritional 
deficiencies and others (Francos et al., 1977). For the 
repeat breeder cows suspected to have an infectious 
etiology, many of the treatments used have been in the 
form of uterine infusions with a variety of antiseptic 
and antibiotic solutions. The intrauterine infusions in 
repeat breeders has proven to be successful (Oxender 
and Seguin, 1976).Therapeutic use of GnRH and PGF2α 
for repeat breeders has been demonstrated with some 
improvement in pregnancy rate compared to untreated 
controls during the last two decades (Peters, 2005; 
Ahuja et al., 2005). 
Purebred dairy cows have been imported since long 
from western to the tropical or subtropical countries for 
enhanced milk production. Undoubtedly, their 
production is high but adaptability particularly during 
hot and humid months is compromised. They are more 
prone to parasitic infestation (Afzal et al., 1986). 
Similarly, pure or crossbred cows maintained in 
subtropical environment have more reproductive 
disorders. In Pakistan, very high incidence (47.5%) of 
repeat breeding due to uterine infections has been 
reported in crossbred dairy cows (Kakar et al., 1997). 
This could be due to the natural service by infected 
bull, as a sequel of post-partum prolapse, retained fetal 
membranes, dystokia, abortion, handling of prolonged 
parturition by the unskilled person, inappropriate 
insemination and/or improper sterilization of 
insemination equipment, inflation of air and insertion of 
tail into vagina and other unexplained reasons. 
The objective of the present study was to determine 
the effect of selective antibiotic treatment of either 
gentamicin or enrofloxacin on pregnancy rate in repeat 
breeder dairy crossbred cows.  
 
MATERIALS AND METHODS 
 
Animals and management 
The present study was conducted on 36 Holstein 
Friesian x Sahiwal crossbred cows maintained at the 
Rakh Dera Chahal, Lahore, Pakistan. Of these, 22 cows 
had the history of repeat breeding (availed six to eight Pakistan Vet. J., 2008, 28(1): 40-42. 
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services but failed to conceive), whereas other 14 were 
control. The cows had moderate body condition with 
body weight ranged from 350 to 450 kg. Parity was 
from 2 to 6 and the average milk production ranged 
from 2500 to 3000 liters per lactation. Throughout the 
experimental period, the cows were maintained as a 
group and were housed in semi-covered sheds under 
similar conditions of feeding and management. Each 
day, cows were fed 30-40 kg of green fodder and 1-2 kg 
of concentrate mixture containing 15% crude protein 
and 65% total digestible nutrients. 
 
Treatments 
All the experimental cows were palpated per 
rectum and scanned by transrectal ultrasonography 
(Falco Vet 100; Pie Med; Holland) to make sure that 
the cows were not pregnant and genitalia was normal. 
Uterine swabs were collected from the cows having the 
history of repeat breeding (n = 22) for culture and 
antibiotic sensitivity test under sterile conditions. The 
antibiotics used in the test were gentamycin, 
kanamycin, oxytetracycline, penicillin, chloram-
phenicol, norfloxacin and enrofloxacin. Based upon 
results of culture and sensitivity test (+ + + or more), 
cows were assigned into two groups. Genta (n = 10) 
cows were treated with gentamycin (100 mg/ml; Farvet, 
Italy) intramuscularly at the dose of 4 ml/100 kg body 
weight and intra-uterine 2-4 ml diluted with 16 ml of 
physiological saline solution. Enro (n = 12) cows were 
treated with enrofloxacin (100 mg/ml; Vetycare, 
Pakistan) intramuscularly at the dose of 4 ml/100 kg 
body weight and intra-uterine 2-4 ml diluted with 16 ml 
of physiological saline solution (five infusions per 
animal, on every other day basis, over a period of 10 
days) with 24 hours interval for five days in both 
groups. Control (n = 14) cows did not receive any 
treatment and served as control (non-repeat breeder). 
After the end of antibiotic therapy, both the groups 
were given sexual rest of at least one month.  
Induction of estrus 
At the end of sexual rest, cows were synchronized 
with two injections of 0.150 mg/2 ml of PGF2α 
(Dalmazin™ Fatro Co. Italy) i.m; 12 h apart after the 
detection of corpus luteum by transrectal 
ultrasonography. Cows were observed for oestrus, two 
times a day using a teaser bull. Cows in estrus were 
inseminated approximately 12 h after the standing heat 
using frozen thawed semen. The cows were 
inseminated by a single technician. Pregnancy 
diagnosis was performed using ultrasonography 
between days 25 and 30 post insemination. The cows 
which returned to estrus were again inseminated 
(second service), and checked for pregnancy. Similarly 
cows that returned to estrus twice were inseminated 
(third service) and checked for pregnancy accordingly. 
      
Statistical analysis 
The differences in pregnancy rates among cows of 
three groups were compared for the first, second, third 
service and overall pregnancy rate using Pearson χ
2-test 
(SPSS version 10.0). The difference between two 
proportions (each of two groups) was compared using 
Z-test (PH Stat 2, Microsoft Excel 2002). 
 
RESULTS 
 
    The pregnancy rates in repeat breeder dairy crossbred 
cows are presented in Table 1. Pregnancy rates for first 
service among three groups tended to be different 
(P<0.05). The pregnancy rate of first service for Genta 
cows (40%) did not differ significantly (P>0.05) with 
Control cows (50%). However, pregnancy rates of first 
service for Enro cows (8%) was lower (P<0.05) than 
Control and Genta cows. The overall pregnancy rates 
among three groups were significantly different 
(P<0.05). The overall pregnancy rate of Genta cows 
(80%) did not differ significantly (P>0.05) with Control 
cows (93%). However, overall pregnancy rates of Enro 
cows (33%) were lower (P<0.05) than Genta and 
Control cows. The overall pregnancy rate of both the 
treated groups was 55%.   
Table 1: Effect of antibiotic treatment on pregnancy rate of repeat breeder dairy crossbred cows with  
sub-clinical uterine infection 
Pregnancy rates (%)  Group No.  of 
cows  First    service  Second service  Third service  Overall 
Genta
┼ 10  (4/10)  40 
a  (3/10) 30  (1/10) 10  (8/10) 80 
a 
Enro 
┼┼ 12  (1/12)  8 
b  (2/12) 16   (1/12) 8  (4/12) 33
 b 
Control
┼┼┼ 14   (7/14)  50 
a (2/14)  14 
   (4/14) 29   (13/14) 93
a  
Values within columns with different letters are significantly different (P<0.05). 
┼ Gentamycin (100 mg/ml; Farvet) intramuscularly 4 ml/100 kg body weight and intra-uterine 2-4 ml diluted with 
16 ml of physiological salt solution.  
┼┼ Enrofloxacin (100 mg/ml; Vetycare) intramuscularly 4 ml/100 kg body weight and intra-uterine 2-4 ml diluted 
with 16 ml of physiological salt solution.  
┼┼┼ Control cows were untreated. 
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DISCUSSION 
 
In the present study, the overall pregnancy rates of 
Genta cows (80%) did not differ significantly with 
Control cows (93%) but were better than Enro cows 
(33%). The overall pregnancy rate of both the treated 
groups was 55%. LeBlanc et al. (2002) administered 
cephapirin benzathine by intrauterine route, and 
obtained improved fertility (P<0.05) over controls in 
endometritic cows. On the other hand, gentamycin 
sulphate administered by intrauterine infusion at the 
rate of 200 mg, 10 minutes following first service 
insemination in dairy cows did not enhance fertility 
(Daniels  et al., 1976). In the present study, higher 
overall pregnancy rates in Genta compared to Enro 
cows might be due to differences in the 
pharmacokinetic characteristics of two antibiotics. For 
example, half-life (t½) and bioavailability have been 
reported to be higher in gentamycin and were 45 hours 
and 92% (Haddad et al., 1987) versus 6 hours and 82% 
respectively for enrofloxacin (Kaartinen et al., 1995). 
Gentamycin when administered intrauterine attained 
maximum plasma concentration within 30 minutes (al-
Guedawy et al., 1983). These findings indicate that 
physiochemical characteristics of gentamycin are better 
compared to enrofloxacin in these repeat breeder cows. 
In conclusion, overall pregnancy rates in repeat 
breeder dairy crossbred cows with sub-clinical uterine 
infection were improved by the treatment of antibiotics 
along with sexual rest up to 55% after three services. 
Furthermore, pregnancy rate of gentamycin was 
significantly higher compared to enrofloxacin in repeat 
breeder dairy crossbred cows.  
 
REFERENCES 
 
Afzal, M., R. M. Nagra, M. Hussain and A. S. Akhtar, 
1986. Health problems in pure-bred exotic and 
crossbred dairy cattle. National Workshop on Dairy 
Cattle Crossbreeding and Maintenance of Exotic 
Dairy Cattle in Pakistan. Pakistan Agri. Res. 
Council, Islamabad, Pakistan.   
Al-Guedawy, S. S., C. A. Neff-Davis, L. E. Davis, H. 
L. Whitmore and B. K. Gustafusson, 1983. 
Disposition of gentamycin in the genital tract of 
cows. J. Vet. Pharmacol. Therap., 6: 85-92.  
Ahuja, C., F. Montiel, R. Canseco, E. Silva and G. 
Mapes, 2005. Pregnancy rate following GnRH + 
PGF2α treatment of low body condition, anestrous 
Bos taurus by Bos indicus crossbred cows during 
the summer months in a tropical environment. 
Anim. Reprod. Sci., 63: 202–213. 
Bartlett, P. C., J. H. Kirk and E. C. Mather, 1986. 
Repeated insemination in Michigan Holstein 
Friesian cattle: Incidence, descriptive epidemiology 
and estimated economic impact. Theriogenology, 
26: 309–322. 
Daniels, W. H., D. A. Morrow, B. W. Pickett and L. 
Ball, 1976. Effects of intrauterine infusion of 
gentamycin sulfate on bovine fertility. Therio-
genology, 6: 61-64.   
Dekriuf, A., 1978. Factors influencing the fertility of a 
cattle population. J. Reprod. Fert., 54: 507–518. 
Francos, G., M. Davidson and E. Mayer, 1977. The 
influence of some nutritional factors on the 
incidence of the repeat breeder syndrome in high 
producing herds. Theriogenology, 7: 105–111. 
Gustafsson, H., K. Larsson, H. Kindahl and A. Madej, 
1986. Sequential endocrine changes and behaviour 
during estrus and metoestrus in repeat breeder and 
virgin estrus and metoestrus heifers. Anim. Reprod. 
Sci., 10: 261–273. 
Haddad, N. S., W. R. Ravis, W. M. Pedersoli and R. L. 
J. R. Carson, 1987. Pharmacokinetics and residues 
of gentamycin in lactating cows after multiple 
intramuscular doses are administered.  Amer. J. 
Vet. Res., 48: 21-27. 
Kaartinen, L., M. Salonen, L. Älli and S. Pyörälä, 1995. 
Pharmacokinetics of enrofloxacin after single 
intravenous, intramuscular and subcutaneous 
injections in cows. J. Vet. Pharmacol. Therap., 18: 
357-362. 
Kakar, M. A., G. Rasool and F. Ahmad, 1997. Clinical 
incidence of reproductive disorders in crossbred 
cows in the province of Balochistan. Pakistan Vet. 
J., 17: 9-12.      
Kimura, M., T. Nakao, M. Moriyoshi and K. Kawata, 
1987. Luteal phase deficiency as a possible cause 
of repeat breeding in dairy cows. British Vet. J., 
143: 560–566. 
LeBlanc, S. J., T. F. Duffield, K. E. Leslie, K. G. 
Bateman, G. P. Keefe, J. S. Walton and W. H. 
Johnson, 2002. The effect of treatment of clinical 
endometritis on reproductive performance in dairy 
cows. J. Dairy Sci., 85: 2237-2249.   
Oxender, W. D.  and B. E. Seguin, 1976. Bovine 
intrauterine therapy. J. Amer. Vet. Med. Assoc., 
168: 217-219. 
Peters, A. R., 2005. Veterinary clinical application of 
GnRH: questions of efficacy. Anim. Reprod. Sci., 
30: 1-13. 
Rao, A. V. N., 1982. Causes and incidence of 
reproductive disorders among Zebu x Taurus 
crossbred cows in Andhra Pradesh. 
Theriogenology, 17: 189-191.  
Roberts, S. J., 1971.Veterinary Obstetrics and Genital 
Diseases (Theriogenology). Published by the 
Author, Ithaca, New York, USA, pp: 496-506. 